Lv31
270 积分 2025-02-12 加入
Prognostic Impact of Non-predominant Lepidic Components in Pathologic Stage I Invasive Non-Mucinous Adenocarcinoma
1个月前
已完结
Efgartigimod: A Review in Generalised Myasthenia Gravis
2个月前
已完结
Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial
2个月前
已完结
皖公网安备34019202002308
